411,221 Shares in Humana Inc. $HUM Acquired by Deutsche Bank AG

Deutsche Bank AG bought a new position in Humana Inc. (NYSE:HUM) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 411,221 shares of the insurance provider’s stock, valued at approximately $163,345,000.

Several other institutional investors also recently bought and sold shares of the business. Vanguard Group Inc. boosted its holdings in shares of Humana by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock worth $3,652,890,000 after purchasing an additional 106,030 shares during the last quarter. Capital International Investors increased its stake in Humana by 113.9% in the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after purchasing an additional 3,097,571 shares during the last quarter. Pzena Investment Management LLC increased its stake in Humana by 34.3% in the first quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock valued at $948,614,000 after purchasing an additional 1,398,774 shares during the last quarter. State Street Corp lifted its position in Humana by 1.8% during the fourth quarter. State Street Corp now owns 5,462,549 shares of the insurance provider’s stock worth $1,403,877,000 after buying an additional 97,211 shares during the period. Finally, Geode Capital Management LLC lifted its position in Humana by 0.8% during the fourth quarter. Geode Capital Management LLC now owns 3,184,569 shares of the insurance provider’s stock worth $812,540,000 after buying an additional 23,732 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have commented on HUM. Robert W. Baird set a $390.00 price target on Humana in a report on Thursday, July 30th. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $425.00 price objective on shares of Humana in a research note on Wednesday, June 3rd. Raymond James Financial lowered shares of Humana from an “outperform” rating to a “market perform” rating in a report on Thursday, July 30th. Lake Street Capital initiated coverage on shares of Humana in a research report on Thursday, July 30th. They issued a “buy” rating on the stock. Finally, Guggenheim boosted their target price on shares of Humana from $269.00 to $471.00 and gave the company a “buy” rating in a report on Thursday, July 30th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $395.22.

Humana Price Performance

Shares of NYSE HUM opened at $377.18 on Thursday. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $428.88. The business has a 50-day moving average of $383.16 and a 200-day moving average of $279.59. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. The company has a market capitalization of $45.29 billion, a price-to-earnings ratio of 35.68, a PEG ratio of 2.18 and a beta of 0.72.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, beating the consensus estimate of $7.27 by $0.34. The business had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business’s quarterly revenue was up 26.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.27 earnings per share. On average, equities analysts anticipate that Humana Inc. will post 9.08 EPS for the current fiscal year.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.